Cannabis Bioscience International Holdings, Inc.
CBIH
$0.00
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Revenue | -64.03% | -65.13% | -58.21% | 21.78% | 56.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -64.03% | -65.13% | -58.21% | 21.78% | 56.82% |
| Cost of Revenue | -42.64% | 12.14% | -11.95% | -12.06% | -11.99% |
| Gross Profit | -67.33% | -74.11% | -65.01% | 29.27% | 77.94% |
| SG&A Expenses | -21.22% | -24.73% | -28.40% | 1.23% | -29.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.66% | -22.76% | -27.38% | 0.38% | -28.68% |
| Operating Income | -22.47% | -21.94% | -1.28% | 11.17% | 55.25% |
| Income Before Tax | -8.94% | -18.29% | -1.69% | 15.75% | 40.25% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.94% | -18.29% | -1.69% | 15.75% | 40.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.94% | -18.29% | -1.69% | 15.75% | 40.25% |
| EBIT | -22.47% | -21.94% | -1.28% | 11.17% | 55.25% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 9.58% | 8.35% | 6.06% | 3.56% | 2.77% |
| Average Diluted Shares Outstanding | 9.58% | 8.35% | 6.06% | 3.56% | 2.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |